A-1210477
CAS1668553-26-1
⚠ This product is for research use only, not for human or veterinary use.
We typically respond within 1 business day.
| CAS Number | 1420477-60-6 |
| IUPAC Name | 4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide |
| Synonyms | acalabrutinibum; ACP-196; CHEBI:167707; 4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide |
| Molecular Weight | 465.50 g/mol |
| Molecular Formula | C26H23N7O2 |
| PubChem CID | 71226662 |
| SMILES | CC#CC(=O)N1CCCC1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5 |
| Purity | >98% |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
Acalabrutinib (CAS 1420477-60-6) is a selective, covalent Bruton's tyrosine kinase (BTK) inhibitor with molecular formula C₂₆H₂₃N₇O₂ and MW 465.50 g/mol. It is also known as ACP-196.
Acalabrutinib is reported to irreversibly inhibit BTK by covalently binding to Cys481 within the kinase active site via its acrylamide-derived but-2-ynoyl warhead. This covalent modification blocks downstream B-cell receptor signaling pathways, including PLCγ2 activation and NF-κB nuclear translocation, thereby suppressing B-cell proliferation and survival. Its imidazo[1,5-a]pyrazine scaffold confers selectivity over a broad panel of off-target kinases relative to earlier-generation BTK inhibitors.
Each batch is analyzed by HPLC and ¹H NMR, with a Certificate of Analysis provided on shipment. Available from milligram to kilogram scale, with flexible packaging to meet R&D and scale-up requirements.
All analytical documentation is provided free of charge with every order. Raw spectral data files (NMR, HPLC, LC-MS) are also available on request — just mention it in your enquiry.